George Hill
Stock Analyst at Deutsche Bank
(2.93)
# 1,628
Out of 5,008 analysts
186
Total ratings
53.98%
Success rate
5.84%
Average return
Main Sectors:
Stocks Rated by George Hill
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MCK McKesson | Maintains: Buy | $775 → $856 | $750.13 | +14.11% | 8 | Sep 24, 2025 | |
HQY HealthEquity | Maintains: Buy | $98 → $115 | $88.50 | +29.94% | 18 | Jun 5, 2025 | |
UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $363.66 | -0.46% | 22 | May 14, 2025 | |
CVS CVS Health | Upgrades: Buy | $66 | $77.12 | -14.42% | 5 | Dec 3, 2024 | |
AGL agilon health | Maintains: Hold | $4 → $2 | $1.06 | +88.68% | 16 | Nov 8, 2024 | |
HIMS Hims & Hers Health | Maintains: Hold | $23 → $27 | $57.97 | -53.42% | 4 | Nov 6, 2024 | |
CI The Cigna Group | Maintains: Buy | $398 → $394 | $307.14 | +28.28% | 10 | Nov 4, 2024 | |
CAH Cardinal Health | Maintains: Hold | $119 → $124 | $156.65 | -20.84% | 12 | Nov 4, 2024 | |
TDOC Teladoc Health | Maintains: Hold | $10 → $12 | $8.37 | +43.37% | 18 | Nov 1, 2024 | |
HUM Humana | Maintains: Hold | $349 → $250 | $295.25 | -15.33% | 11 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $4.96 | -59.68% | 14 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $37.91 | -18.23% | 2 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $3.19 | +56.74% | 4 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $38.42 | +126.44% | 10 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $203.26 | +73.67% | 9 | Jul 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $276.93 | +70.08% | 2 | Sep 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $4.39 | +82.23% | 5 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $581 → $571 | $357.49 | +59.72% | 2 | Mar 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $200.86 | +24.46% | 4 | Mar 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $186.65 | +25.90% | 5 | Feb 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $170.10 | +96.36% | 5 | Feb 18, 2021 |
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $750.13
Upside: +14.11%
HealthEquity
Jun 5, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $88.50
Upside: +29.94%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $363.66
Upside: -0.46%
CVS Health
Dec 3, 2024
Upgrades: Buy
Price Target: $66
Current: $77.12
Upside: -14.42%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $1.06
Upside: +88.68%
Hims & Hers Health
Nov 6, 2024
Maintains: Hold
Price Target: $23 → $27
Current: $57.97
Upside: -53.42%
The Cigna Group
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $307.14
Upside: +28.28%
Cardinal Health
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $156.65
Upside: -20.84%
Teladoc Health
Nov 1, 2024
Maintains: Hold
Price Target: $10 → $12
Current: $8.37
Upside: +43.37%
Humana
Oct 3, 2024
Maintains: Hold
Price Target: $349 → $250
Current: $295.25
Upside: -15.33%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $4.96
Upside: -59.68%
Aug 14, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $37.91
Upside: -18.23%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $3.19
Upside: +56.74%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $38.42
Upside: +126.44%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $203.26
Upside: +73.67%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $276.93
Upside: +70.08%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $4.39
Upside: +82.23%
Mar 8, 2023
Maintains: Buy
Price Target: $581 → $571
Current: $357.49
Upside: +59.72%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $200.86
Upside: +24.46%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $186.65
Upside: +25.90%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $170.10
Upside: +96.36%